Previous Close | 1.5900 |
Open | 1.6500 |
Bid | 1.7700 x 400 |
Ask | 1.7900 x 300 |
Day's Range | 1.6100 - 1.8000 |
52 Week Range | 1.1200 - 3.5200 |
Volume | |
Avg. Volume | 161,603 |
Market Cap | 95.353M |
Beta (5Y Monthly) | 1.73 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.1300 |
Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.25 |
Key Insights The considerable ownership by individual investors in Milestone Pharmaceuticals indicates that they...
Learnings from the Field: Managing PSVT and Studying AFib-RVR in the Community Setting Hosted 10 am ET, Tuesday, October 8, 2024 MONTREAL and CHARLOTTE, N.C., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced it will host Part 2 of its virtual investor education series on Tuesday, October 8, 2024 from 10:00 AM ET to 11:30 AM ET. To